646 related articles for article (PubMed ID: 21835883)
21. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
22. Critical regions and spreading of runt-related transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma.
Ge MH; Chen C; Xu JJ; Ling ZQ
Hum Pathol; 2011 Dec; 42(12):1862-72. PubMed ID: 21658745
[TBL] [Abstract][Full Text] [Related]
23. Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning.
Patel SA; Graunke DM; Pieper RO
Mol Cell Biol; 1997 Oct; 17(10):5813-22. PubMed ID: 9315639
[TBL] [Abstract][Full Text] [Related]
24. Human genes with CpG island promoters have a distinct transcription-associated chromatin organization.
Vavouri T; Lehner B
Genome Biol; 2012 Nov; 13(11):R110. PubMed ID: 23186133
[TBL] [Abstract][Full Text] [Related]
25. Nucleosome Occupancy and Methylome Sequencing (NOMe-seq).
Lay FD; Kelly TK; Jones PA
Methods Mol Biol; 2018; 1708():267-284. PubMed ID: 29224149
[TBL] [Abstract][Full Text] [Related]
26. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
27. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
Woellmer A; Arteaga-Salas JM; Hammerschmidt W
PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
[TBL] [Abstract][Full Text] [Related]
28. Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer.
Zhang X; Wu M; Xiao H; Lee MT; Levin L; Leung YK; Ho SM
Prostate; 2010 May; 70(7):765-76. PubMed ID: 20054818
[TBL] [Abstract][Full Text] [Related]
29. Nucleosome dynamics and maintenance of epigenetic states of CpG islands.
Sneppen K; Dodd IB
Phys Rev E; 2016 Jun; 93(6):062417. PubMed ID: 27415308
[TBL] [Abstract][Full Text] [Related]
30. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract][Full Text] [Related]
31. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
[TBL] [Abstract][Full Text] [Related]
33. The role of DNA methylation in directing the functional organization of the cancer epigenome.
Lay FD; Liu Y; Kelly TK; Witt H; Farnham PJ; Jones PA; Berman BP
Genome Res; 2015 Apr; 25(4):467-77. PubMed ID: 25747664
[TBL] [Abstract][Full Text] [Related]
34. CpG island methylation status in the EpCAM promoter region and gene expression.
Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y
Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide positioning of bivalent mononucleosomes.
Sen S; Block KF; Pasini A; Baylin SB; Easwaran H
BMC Med Genomics; 2016 Sep; 9(1):60. PubMed ID: 27634286
[TBL] [Abstract][Full Text] [Related]
36. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
37. Nucleosomes at active promoters: unforgettable loss.
Henikoff S
Cancer Cell; 2007 Nov; 12(5):407-9. PubMed ID: 17996642
[TBL] [Abstract][Full Text] [Related]
38. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
39. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.
Kodach LL; Jacobs RJ; Heijmans J; van Noesel CJ; Langers AM; Verspaget HW; Hommes DW; Offerhaus GJ; van den Brink GR; Hardwick JC
Carcinogenesis; 2010 Sep; 31(9):1567-75. PubMed ID: 20631058
[TBL] [Abstract][Full Text] [Related]
40. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.
O'Hagan HM; Mohammad HP; Baylin SB
PLoS Genet; 2008 Aug; 4(8):e1000155. PubMed ID: 18704159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
